DEUTSCHE BETEILIGUNGS AG (DBAN.DE) Stock Fundamental Analysis
FRA:DBAN - Deutsche Boerse Ag - DE000A1TNUT7 - Common Stock - Currency: EUR
We assign a fundamental rating of 5 out of 10 to DBAN. DBAN was compared to 107 industry peers in the Capital Markets industry. While DBAN has a great health rating, its profitability is only average at the moment. DBAN is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
DBAN had positive earnings in the past year.
In the past year DBAN had a positive cash flow from operations.
In multiple years DBAN reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: DBAN reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of 6.29%, DBAN is in the better half of the industry, outperforming 79.44% of the companies in the same industry.
DBAN has a Return On Equity of 8.26%. This is comparable to the rest of the industry: DBAN outperforms 54.21% of its industry peers.
DBAN has a Return On Invested Capital of 4.84%. This is in the better half of the industry: DBAN outperforms 68.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.29% | ||
| ROE | 8.26% | ||
| ROIC | 4.84% |
ROA(3y)1.68%
ROA(5y)5.34%
ROE(3y)1.96%
ROE(5y)5.68%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DBAN has a better Profit Margin (43.12%) than 86.92% of its industry peers.
DBAN's Profit Margin has declined in the last couple of years.
DBAN has a Operating Margin of 45.95%. This is amongst the best in the industry. DBAN outperforms 84.11% of its industry peers.
In the last couple of years the Operating Margin of DBAN has declined.
With an excellent Gross Margin value of 93.60%, DBAN belongs to the best of the industry, outperforming 87.85% of the companies in the same industry.
DBAN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 45.95% | ||
| PM (TTM) | 43.12% | ||
| GM | 93.6% |
OM growth 3Y-18.51%
OM growth 5Y-4.58%
PM growth 3Y-19.55%
PM growth 5Y-6.09%
GM growth 3Y-1.43%
GM growth 5Y-0.83%
2. Health
2.1 Basic Checks
DBAN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for DBAN has been increased compared to 5 years ago.
Compared to 1 year ago, DBAN has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.94 indicates that DBAN is not a great score, but indicates only limited risk for bankruptcy at the moment.
DBAN has a better Altman-Z score (2.94) than 71.03% of its industry peers.
The Debt to FCF ratio of DBAN is 4.14, which is a neutral value as it means it would take DBAN, 4.14 years of fcf income to pay off all of its debts.
DBAN has a better Debt to FCF ratio (4.14) than 77.57% of its industry peers.
DBAN has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of DBAN (0.20) is better than 70.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 4.14 | ||
| Altman-Z | 2.94 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
DBAN has a Current Ratio of 6.68. This indicates that DBAN is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of DBAN (6.68) is better than 91.59% of its industry peers.
A Quick Ratio of 6.68 indicates that DBAN has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 6.68, DBAN belongs to the best of the industry, outperforming 91.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.68 | ||
| Quick Ratio | 6.68 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 0.70% over the past year.
The Earnings Per Share has been decreasing by -3.13% on average over the past years.
DBAN shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.52%.
DBAN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.25% yearly.
EPS 1Y (TTM)0.7%
EPS 3Y-38.96%
EPS 5Y-3.13%
EPS Q2Q%-70.3%
Revenue 1Y (TTM)22.52%
Revenue growth 3Y-21%
Revenue growth 5Y7.25%
Sales Q2Q%-44.94%
3.2 Future
Based on estimates for the next years, DBAN will show a very negative growth in Earnings Per Share. The EPS will decrease by -14.48% on average per year.
The Revenue is expected to decrease by -0.23% on average over the next years.
EPS Next Y-39.86%
EPS Next 2Y-17.52%
EPS Next 3Y-14.48%
EPS Next 5YN/A
Revenue Next Year-12.69%
Revenue Next 2Y-3.2%
Revenue Next 3Y-0.23%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 9.90, which indicates a very decent valuation of DBAN.
Compared to the rest of the industry, the Price/Earnings ratio of DBAN indicates a rather cheap valuation: DBAN is cheaper than 82.24% of the companies listed in the same industry.
DBAN is valuated cheaply when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 7.61 indicates a rather cheap valuation of DBAN.
Based on the Price/Forward Earnings ratio, DBAN is valued cheaper than 96.26% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.33, DBAN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.9 | ||
| Fwd PE | 7.61 |
4.2 Price Multiples
DBAN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DBAN is cheaper than 83.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.09 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A cheap valuation may be justified as DBAN's earnings are expected to decrease with -14.48% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.52%
EPS Next 3Y-14.48%
5. Dividend
5.1 Amount
DBAN has a Yearly Dividend Yield of 3.78%.
DBAN's Dividend Yield is a higher than the industry average which is at 5.87.
DBAN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.35.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.78% |
5.2 History
The dividend of DBAN decreases each year by -5.78%.
Dividend Growth(5Y)-5.78%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
DBAN's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP0%
EPS Next 2Y-17.52%
EPS Next 3Y-14.48%
FRA:DBAN (7/15/2025, 5:29:57 PM)
25.65
+0.05 (+0.2%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners13.1%
Inst Owner ChangeN/A
Ins Owners10%
Ins Owner ChangeN/A
Market Cap482.22M
Analysts89.23
Price Target41.06 (60.08%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.78% |
Yearly Dividend1.01
Dividend Growth(5Y)-5.78%
DP0%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.58%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-11.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.9 | ||
| Fwd PE | 7.61 | ||
| P/S | 3.86 | ||
| P/FCF | 15.09 | ||
| P/OCF | 14.72 | ||
| P/B | 0.74 | ||
| P/tB | 0.8 | ||
| EV/EBITDA | N/A |
EPS(TTM)2.59
EY10.1%
EPS(NY)3.37
Fwd EY13.13%
FCF(TTM)1.7
FCFY6.63%
OCF(TTM)1.74
OCFY6.79%
SpS6.65
BVpS34.75
TBVpS32.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.29% | ||
| ROE | 8.26% | ||
| ROCE | 6.87% | ||
| ROIC | 4.84% | ||
| ROICexc | 5.19% | ||
| ROICexgc | 5.54% | ||
| OM | 45.95% | ||
| PM (TTM) | 43.12% | ||
| GM | 93.6% | ||
| FCFM | 25.55% |
ROA(3y)1.68%
ROA(5y)5.34%
ROE(3y)1.96%
ROE(5y)5.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-35.11%
ROICexcg growth 5Y-7.26%
ROICexc growth 3Y-36.76%
ROICexc growth 5Y-8.68%
OM growth 3Y-18.51%
OM growth 5Y-4.58%
PM growth 3Y-19.55%
PM growth 5Y-6.09%
GM growth 3Y-1.43%
GM growth 5Y-0.83%
F-Score6
Asset Turnover0.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 4.14 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.65% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 59.24% | ||
| Current Ratio | 6.68 | ||
| Quick Ratio | 6.68 | ||
| Altman-Z | 2.94 |
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.91%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.7%
EPS 3Y-38.96%
EPS 5Y-3.13%
EPS Q2Q%-70.3%
EPS Next Y-39.86%
EPS Next 2Y-17.52%
EPS Next 3Y-14.48%
EPS Next 5YN/A
Revenue 1Y (TTM)22.52%
Revenue growth 3Y-21%
Revenue growth 5Y7.25%
Sales Q2Q%-44.94%
Revenue Next Year-12.69%
Revenue Next 2Y-3.2%
Revenue Next 3Y-0.23%
Revenue Next 5YN/A
EBIT growth 1Y14.61%
EBIT growth 3Y-35.63%
EBIT growth 5Y2.34%
EBIT Next Year-23.9%
EBIT Next 3Y0.97%
EBIT Next 5YN/A
FCF growth 1Y242.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y251.24%
OCF growth 3YN/A
OCF growth 5YN/A